Xiaoliang Dong

990 total citations
35 papers, 756 citations indexed

About

Xiaoliang Dong is a scholar working on Molecular Biology, Immunology and Surgery. According to data from OpenAlex, Xiaoliang Dong has authored 35 papers receiving a total of 756 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 7 papers in Immunology and 6 papers in Surgery. Recurrent topics in Xiaoliang Dong's work include Glutathione Transferases and Polymorphisms (5 papers), Epigenetics and DNA Methylation (5 papers) and Genomics, phytochemicals, and oxidative stress (3 papers). Xiaoliang Dong is often cited by papers focused on Glutathione Transferases and Polymorphisms (5 papers), Epigenetics and DNA Methylation (5 papers) and Genomics, phytochemicals, and oxidative stress (3 papers). Xiaoliang Dong collaborates with scholars based in China, Sweden and Netherlands. Xiaoliang Dong's co-authors include Lan Luo, Li‐Long Pan, Jia Sun, Xiaohua Pan, Zhimin Yin, Peng Cao, Shaoxu Wu, Xu Chen, Zhuowei Liu and Hong Zeng and has published in prestigious journals such as Journal of Agricultural and Food Chemistry, Biochemical and Biophysical Research Communications and The Journal of Urology.

In The Last Decade

Xiaoliang Dong

30 papers receiving 751 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaoliang Dong China 15 344 206 200 92 86 35 756
Qinggao Zhang China 20 404 1.2× 131 0.6× 243 1.2× 82 0.9× 52 0.6× 51 919
Yuzhen Zhuo China 17 385 1.1× 114 0.6× 216 1.1× 161 1.8× 98 1.1× 46 793
Shanshan Wu China 17 283 0.8× 90 0.4× 158 0.8× 54 0.6× 62 0.7× 31 714
Yong‐Seok Song United States 15 285 0.8× 159 0.8× 98 0.5× 54 0.6× 115 1.3× 50 693
Yeon Ho Choi South Korea 19 381 1.1× 161 0.8× 165 0.8× 57 0.6× 93 1.1× 34 813
Wei‐Jan Wang Taiwan 16 419 1.2× 104 0.5× 98 0.5× 68 0.7× 108 1.3× 42 842
Maowen Hu United States 11 281 0.8× 145 0.7× 192 1.0× 61 0.7× 89 1.0× 13 762
Huijuan Shen China 15 339 1.0× 108 0.5× 135 0.7× 42 0.5× 177 2.1× 53 731
Valery N. Bochkov Austria 14 542 1.6× 87 0.4× 203 1.0× 67 0.7× 63 0.7× 16 925
Simiao Qiao China 16 434 1.3× 83 0.4× 172 0.9× 73 0.8× 69 0.8× 32 865

Countries citing papers authored by Xiaoliang Dong

Since Specialization
Citations

This map shows the geographic impact of Xiaoliang Dong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoliang Dong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoliang Dong more than expected).

Fields of papers citing papers by Xiaoliang Dong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoliang Dong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoliang Dong. The network helps show where Xiaoliang Dong may publish in the future.

Co-authorship network of co-authors of Xiaoliang Dong

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoliang Dong. A scholar is included among the top collaborators of Xiaoliang Dong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoliang Dong. Xiaoliang Dong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pan, Li‐Long, Zhengnan Ren, Binbin Li, et al.. (2025). Coactosin‐Like Protein Reduces Prostaglandin D 2 Production in Alveolar Macrophages and Alleviates Allergic Airway Inflammation. Advanced Science. 12(34). e01673–e01673.
3.
Liang, Wenjie, et al.. (2025). Bilirubin prevents hyperlipidaemic acute pancreatitis by inhibiting aryl hydrocarbon receptor‐mediated acinar cell pyroptosis. British Journal of Pharmacology. 182(23). 5899–5912.
4.
Pan, Xiaohua, Zhengnan Ren, Wenjie Liang, et al.. (2025). Thiamine deficiency aggravates experimental colitis in mice by promoting glycolytic reprogramming in macrophages. British Journal of Pharmacology. 182(9). 1897–1911. 3 indexed citations
5.
Yang, H.H. Clarice, et al.. (2025). Gut microbiota-derived butyrate prevents aortic dissection via GPR41. Acta Pharmacologica Sinica. 46(12). 3230–3243.
6.
He, Lulu, et al.. (2024). Millimeter-scale Na2SiF6:Mn4+ red-emitting crystals with intense zero phonon line at 617 nm and enhanced hydrolysis resistance. Ceramics International. 51(6). 8034–8041. 4 indexed citations
7.
Yang, Jun, et al.. (2024). Intestinal GSTpi deficiency exacerbates the severity of experimental hyperlipidemic acute pancreatitis. International Immunopharmacology. 137. 112363–112363. 2 indexed citations
9.
Dong, Xiaoliang, Juan Xiong, Bingxin Wang, et al.. (2024). Shizukaol C alleviates trimethylamine oxide-induced inflammation through activating Keap1-Nrf2-GSTpi pathway in vascular smooth muscle cell. Phytomedicine. 128. 155403–155403. 4 indexed citations
10.
Ren, Zhengnan, Xiaohua Pan, Jiahong Li, et al.. (2023). G protein coupled receptor 41 regulates fibroblast activation in pulmonary fibrosis via Gαi/o and downstream Smad2/3 and ERK1/2 phosphorylation. Pharmacological Research. 191. 106754–106754. 9 indexed citations
11.
Wu, Di, Bo Wu, Xiaohua Pan, et al.. (2023). Formononetin alleviates acute pancreatitis by reducing oxidative stress and modulating intestinal barrier. Chinese Medicine. 18(1). 78–78. 10 indexed citations
12.
Ren, Zhengnan, Li‐Long Pan, Yi‐Wen Huang, et al.. (2021). Gut microbiota‐CRAMP axis shapes intestinal barrier function and immune responses in dietary gluten‐induced enteropathy. EMBO Molecular Medicine. 13(8). e14059–e14059. 23 indexed citations
13.
Liu, He, Xiaoliang Dong, Xiaohua Pan, et al.. (2021). A Novel Resveratrol Analog Upregulates SIRT1 Expression and Ameliorates Neointima Formation. Frontiers in Cardiovascular Medicine. 8. 756098–756098. 6 indexed citations
14.
Dong, Xiaoliang, Yang Yang, Yi Zhou, et al.. (2019). Glutathione S-transferases P1 protects breast cancer cell from adriamycin-induced cell death through promoting autophagy. Cell Death and Differentiation. 26(10). 2086–2099. 46 indexed citations
15.
Dong, Xiaoliang. (2018). Glutathione S-Transferase Pi is Involved in the Growth of Mice. The Chinese Journal of Physiology. 61(4). 230–239. 2 indexed citations
16.
Yang, Yang, Ling Li, Yuan Fang, et al.. (2018). γ-glutamylcysteine exhibits anti-inflammatory effects by increasing cellular glutathione level. Redox Biology. 20. 157–166. 67 indexed citations
17.
Yang, Yang, Fangyuan Yin, Xiaoliang Dong, et al.. (2018). Regulation of Endothelial Permeability by Glutathione S-Transferase Pi Against Actin Polymerization. Cellular Physiology and Biochemistry. 45(1). 406–418. 12 indexed citations
18.
Zhang, Zhengping, Rong Chen, Chunmei Wang, et al.. (2015). A novel acetylcholinesterase inhibitor and calcium channel blocker SCR-1693 improves Aβ25–35-impaired mouse cognitive function. Psychopharmacology. 233(4). 599–613. 21 indexed citations
19.
Cheng, Lei, Ming Li, Jing Hu, et al.. (2014). UGT1A1*6 polymorphisms are correlated with irinotecan-induced toxicity: a system review and meta-analysis in Asians. Cancer Chemotherapy and Pharmacology. 73(3). 551–560. 64 indexed citations
20.
Chen, Dan, et al.. (2013). Luteolin exhibits anti-inflammatory effects by blocking the activity of heat shock protein 90 in macrophages. Biochemical and Biophysical Research Communications. 443(1). 326–332. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026